(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 5.64% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Revvity's revenue in 2026 is $2,856,051,000.On average, 23 Wall Street analysts forecast RVTY's revenue for 2026 to be $339,534,698,838, with the lowest RVTY revenue forecast at $322,093,996,494, and the highest RVTY revenue forecast at $351,944,429,352. On average, 22 Wall Street analysts forecast RVTY's revenue for 2027 to be $356,863,601,808, with the lowest RVTY revenue forecast at $339,311,100,090, and the highest RVTY revenue forecast at $373,745,307,282.
In 2028, RVTY is forecast to generate $377,099,288,502 in revenue, with the lowest revenue forecast at $354,404,015,580 and the highest revenue forecast at $398,788,367,058.